Vaxcyte Inc (PCVX)

SG&A Expense Growth

5.61%

Quarterly · Period ending:

PCVX logo

PCVX SG&A Expense Growth

Latest reported5.61%
PCVX Quarterly SG&A Growth (QoQ) (0.00% → 5.61%)
High-resolution chart · PNG

PCVX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vaxcyte Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
5.6061%
2.6317%
-0.6904%
1.2703%
-1.8953%
14.3723%
24.217%
7.0504%
7.9909%
13.46%
12.3102%
7.9483%
10.2502%
9.7055%
9.6715%
15.7269%
24.8442%
11.3851%
3.8173%
7.3038%
3.2965%
22.8088%
-2.1641%
60.8011%
-7.1625%
33.5368%
-2.1116%
10.8657%
72.0365%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.